biblio
, “Cocrystallization of multi-kinase inhibitor pazopanib with fenamic acids: improving dissolution and inhibiting cell migration”, CrystEngComm, vol. 25, no. 39, pp. 5565-5574, 2023.
, “Dabrafenib-panobinostat salt: improving the dissolution rate and inhibition of BRAF melanoma cells”, ACS Omega, vol. 8, no. 20, pp. 18255-18265, 2023.
, “Entacapone polymorphs: crystal structures, dissolution, permeability, and stability”, Crystal Growth & Design, vol. 21, no. 10, pp. 5573-5585, 2021.
, “Improving the dissolution rate of the anticancer drug dabrafenib”, Crystal Growth & Design, vol. 20, no. 2, pp. 1035-1046, 2020.
, “Polymorph II of hydroxyurea 150 years after its first synthesis”, Crystengcomm, vol. 25, no. 18, pp. 2712-2716, 2023.
, “Salts and cocrystal of etodolac: advantage of solubility, dissolution, and permeability”, Crystal Growth & Design, vol. 20, no. 7, pp. 4512-4522, 2020.
, “Salts, solvates and hydrates of the multi-kinase inhibitor drug pazopanib with hydroxybenzoic acids”, Crystengcomm, vol. 23, no. 35, pp. 5994-6011, 2021.
, “Structural, Hirshfeld surface and in vitro cytotoxicity evaluation of five new N-aryl-N'-alkoxycarbonyl thiocarbamide derivatives”, Phosphorus Sulfur and Silicon and the Related Elements, vol. 195, pp. 812-820, 2020.
, “Synthesis, characterisation, Hirshfeld surface and in vitro cytotoxicity evaluation of new N-aryl-N `-Alkoxycarbonyl thiocarbamide derivatives”, Journal of Molecular Structure, vol. 1202, p. 127269, 2020.
, “Synthesis, characterization, Hirshfeld surface, cytotoxicity, DNA damage and cell cycle arrest studies of N, N-diphenyl-N `-(biphenyl-4-carbonyl/4-chlorobenzoyl) thiocarbamides”, Journal of Molecular Structure, vol. 1186, pp. 333-344, 2019.